The company is at the forefront of personalized medicine revolution. Rna Diagnostic"s first product RNA Disruption Assay (RDA) helps oncologists rapidly determine whether chemotherapy is destroying the patients tumor. RDA addresses on of the highest priority problems in oncology - effective cancer chemotherapy management. The awards gala was held at the Toronto Board of Trade on April 18, 2011. Along with Rna Diagnostics, the second place winner was NIMTech Inc. and the New Entrepreneur Award was presented to Clearpath Robotics from the University of Waterloo. TiEQuest 2011 also awarded the Best Clean Tech Award to NIMTech Inc. and the Best Healthcare Industry Award to Rna Diagnostics Inc. Both teams, Rna Diagnostics Inc. and NIMTech Inc. were joint winners of the Best Intellectual Property Award.